The ACR Government Affairs Committee has developed legislative language to limit commercial insurance plans’ cost-sharing requirements for medications in a specialty drug tier to the dollar amount applicable to drugs in the nonpreferred-brand drug tier.
Pediatric Rheumatologists Increasing in Number but Still Rare
Initiatives are growing the ranks and helping to ensure access in remote areas.
The Happiest Specialty: Rheumatology Is #1!
Why are we all smiling, and how can we spread it around?
A Fork in the Road: Advocacy for Rheumatology
Is that fork bent? So you must be a rheumatologist.
Award Targets Critical Shortage of Pediatric Rheumatologists
Deborah Rothman, MD, PhD, received two separate ACR REF/Amgen Pediatric Rheumatology Visiting Professorship Awards, which allowed her to visit programs that do not have either a pediatric rheumatologist or a pediatric rheumatology fellowship program.
The Role of the Social Worker in the Management of Rheumatic Disease
Although social work involvement is far more common in the pediatric world of rheumatology, the role social workers play in the clinic can also be beneficial to adult patients.
Expressing My Point of View Where it Matters Most—In the Halls of Congress
The change that we desire and need is possible in Washington, D.C.
Advocacy: It’s a Full-Contact Sport
Like so many things, it is about personal connections.
Volunteering Is Informative—and Fun
A former ACR board of directors member chronicles his interpretation of the activities of the board over the past three years, highlighting issues that are likely on the minds of ACR members.
Advocating for Rheumatology: A Patient’s Perspective
I have made it my personal goal to ensure that future patients don’t have to go through the same uncertainty and delayed treatment that I went through.
- « Previous Page
- 1
- …
- 19
- 20
- 21
- 22
- 23
- …
- 30
- Next Page »